These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 36286552

  • 1. Synergistic Effect of the Combination of Deferoxamine and Fluconazole In Vitro and In Vivo against Fluconazole-Resistant Candida Spp.
    An L, Tan J, Wang Y, Liu S, Li Y, Yang L.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0072522. PubMed ID: 36286552
    [Abstract] [Full Text] [Related]

  • 2. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y, Ren H, Wang D, Zhang M, Sun S, Zhao Y.
    Biomed Pharmacother; 2020 Oct 15; 130():110580. PubMed ID: 32745913
    [Abstract] [Full Text] [Related]

  • 3. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
    Wang Y, Lu C, Zhao X, Wang D, Liu Y, Sun S.
    Biomed Pharmacother; 2021 Jul 15; 139():111568. PubMed ID: 33845374
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo.
    Li X, Yang H, Duan X, Cui M, Xing W, Zheng S.
    Expert Rev Anti Infect Ther; 2023 Jul 15; 21(11):1259-1267. PubMed ID: 37818633
    [Abstract] [Full Text] [Related]

  • 5. Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.
    Zhu B, Li Z, Yin H, Hu J, Xue Y, Zhang G, Zheng X, Chen W, Hu X.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0147821. PubMed ID: 35297651
    [Abstract] [Full Text] [Related]

  • 6. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against Candida albicans.
    Chen X, Shi Y, Li Y, Su S, Wang P, Sun S.
    Expert Rev Anti Infect Ther; 2021 Jan 27; 19(1):109-115. PubMed ID: 32924656
    [Abstract] [Full Text] [Related]

  • 7. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M, Yan H, Lu M, Wang D, Sun S.
    Int J Antimicrob Agents; 2020 Jan 27; 55(1):105804. PubMed ID: 31605727
    [Abstract] [Full Text] [Related]

  • 8. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic Candida.
    Kane A, Dinh H, Campbell L, Cain AK, Hibbs D, Carter D.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0012124. PubMed ID: 38695556
    [Abstract] [Full Text] [Related]

  • 9. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L, Liao K, Hang C.
    Phytomedicine; 2018 Feb 01; 40():55-58. PubMed ID: 29496175
    [Abstract] [Full Text] [Related]

  • 10. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR, Keniya MV, Ivnitski-Steele I, Monk BC, Lamping E, Sklar LA, Cannon RD.
    Antimicrob Agents Chemother; 2012 Mar 01; 56(3):1508-15. PubMed ID: 22203607
    [Abstract] [Full Text] [Related]

  • 11. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N, Ling G, Liang X, Jin J, Fan J, Qiu J, Song Y, Huang N, Wu X, Wang X, Deng X, Deng X, Yu L.
    Mycoses; 2011 Sep 01; 54(5):e400-6. PubMed ID: 21910756
    [Abstract] [Full Text] [Related]

  • 12. The Inhibitory Effect of Human Beta-defensin-3 on Candida Glabrata Isolated from Patients with Candidiasis.
    Inthanachai T, Thammahong A, Edwards SW, Virakul S, Kiatsurayanon C, Chiewchengchol D.
    Immunol Invest; 2021 Jan 01; 50(1):80-91. PubMed ID: 32316784
    [Abstract] [Full Text] [Related]

  • 13. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP, Liu W, Liu H, Zhu F, Zhang DZ, Shen H, Xu Z, Qi YP, Zhang SQ, Chen SM, He LJ, Cao XJ, Huang X, Zhang JD, Yan L, An MM, Jiang YY.
    PLoS One; 2015 Jan 01; 10(5):e0126393. PubMed ID: 25992630
    [Abstract] [Full Text] [Related]

  • 14. Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans.
    Wu S, Jia W, Lu Y, Jiang H, Huang C, Tang S, Du L.
    BMC Microbiol; 2024 Jun 07; 24(1):196. PubMed ID: 38849761
    [Abstract] [Full Text] [Related]

  • 15. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W, Zhang H, Li C, Li G, Liu X, Wei J.
    BMC Microbiol; 2016 Jun 18; 16(1):113. PubMed ID: 27316338
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant Candida albicans.
    Li Z, Huang Y, Tu J, Yang W, Liu N, Wang W, Sheng C.
    J Med Chem; 2023 Apr 27; 66(8):5950-5964. PubMed ID: 37037787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
    Li Y, Yang J, Li X, Su S, Chen X, Sun S, Li Y.
    Int J Antimicrob Agents; 2020 Aug 27; 56(2):106030. PubMed ID: 32454072
    [Abstract] [Full Text] [Related]

  • 20. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates.
    Xu Y, Quan H, Wang Y, Zhong H, Sun J, Xu J, Jia N, Jiang Y.
    Front Cell Infect Microbiol; 2017 Aug 27; 7():491. PubMed ID: 29238700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.